Forbion European Acquisition Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jasper Bos

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	geen gegevens

Recente managementupdates

Geen updates

Recent updates

CEO

Jasper Bos (48 yo)

no data

Tenure

Dr. Jasper M. Bos, Ph.D. serves as a General Partner at Forbion Capital Partners B.V. since joining the firm in May 2021. He serves as Non-Executive Director at Camel-IDS. He serves as Chief Executive Offi...

Forbion European Acquisition Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Recent updates

Forbion European Acquisition Corp. Files Form 15

Nasdaq Halts Trading of Forbion European Acquisition's Securities and Filed Notification of Removal from Listing and Registration on Form 25

enGene, Inc. completed the acquisition of Forbion European Acquisition Corp. (NasdaqGM:FRBN) from a group of shareholders in a reverse merger transaction.

New major risk - Financial position

New major risk - Share price stability

Forbion European Acquisition Corp. announced that it has received $1.265 million in funding from Forbion Growth Sponsor Feac I B.V.

Forbion European Acquisition Corp. (NasdaqGM:FRBN) entered into a business combination agreement to acquire enGene, Inc from shareholders.

Forbion European Acquisition Corp. (NasdaqGM:FRBN) entered into a business combination agreement to acquire enGene, Inc from shareholders.

Forbion European Acquisition Corp. announced delayed annual 10-K filing

CEO

Tenure